| David Vincent Spurlin, MD | |
|
33301 Woodward Ave, Birmingham, MI 48009-0905 | |
| (248) 642-9111 | |
| (248) 593-1713 |
| Full Name | David Vincent Spurlin |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 31 Years |
| Location | 33301 Woodward Ave, Birmingham, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679500573 | NPI | - | NPPES |
| 104038 | Other | MI | GREAT LAKES HEALTH PLAN |
| 1679500573 | Other | MI | NPI |
| 0706337892 | Other | MI | BLUE CROSS BLUE SHIELD |
| C7166 | Other | MCARE | |
| 5363650 | Other | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 4301064183 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| David V Spurlin, M.d., P.l.l.c. | 2961405071 | 2 |
News Archive
Less than 24 hours after Republicans won control of the House, soon-to-be-speaker John Boehner denounced the new health care law, saying it would "kill jobs in America, ruin the best health care system in the world, and bankrupt our country" - and renewed his vow to try to repeal it. Kaiser Health News asked people around the country to answer the following question: "If you ended up in an elevator with Rep. Boehner, what single thing would you urge him to do about health care in this country? (Kaiser Health News).
Link Resources, Inc. announced today the completion of a share exchange transaction and concurrent US$12 million private placement pursuant to which it acquired the parent company of Yantai Bohai Pharmaceuticals Group Co., Ltd. ("Bohai").
AMAG Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has accepted for review the company's supplemental new drug application (sNDA) for Feraheme (ferumoxytol) Injection for Intravenous (IV) use, which was submitted to the FDA in December 2012.
Two multinational clinical studies indicate that the RDI's system for predicting how HIV and AIDS patients will respond to different drugs could be a useful tool with potential clinical and economic benefits. The studies, published in the January issue of AIDS Patient Care and STDs, involved highly experienced physicians in the USA, Canada and Italy who used the system to help them select the optimum combination of HIV drugs for patients whose therapy was failing.
› Verified 7 days ago
| Entity Name | David V Spurlin, M.d., P.l.l.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578571303 PECOS PAC ID: 2961405071 Enrollment ID: O20060810000226 |
News Archive
Less than 24 hours after Republicans won control of the House, soon-to-be-speaker John Boehner denounced the new health care law, saying it would "kill jobs in America, ruin the best health care system in the world, and bankrupt our country" - and renewed his vow to try to repeal it. Kaiser Health News asked people around the country to answer the following question: "If you ended up in an elevator with Rep. Boehner, what single thing would you urge him to do about health care in this country? (Kaiser Health News).
Link Resources, Inc. announced today the completion of a share exchange transaction and concurrent US$12 million private placement pursuant to which it acquired the parent company of Yantai Bohai Pharmaceuticals Group Co., Ltd. ("Bohai").
AMAG Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has accepted for review the company's supplemental new drug application (sNDA) for Feraheme (ferumoxytol) Injection for Intravenous (IV) use, which was submitted to the FDA in December 2012.
Two multinational clinical studies indicate that the RDI's system for predicting how HIV and AIDS patients will respond to different drugs could be a useful tool with potential clinical and economic benefits. The studies, published in the January issue of AIDS Patient Care and STDs, involved highly experienced physicians in the USA, Canada and Italy who used the system to help them select the optimum combination of HIV drugs for patients whose therapy was failing.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Vincent Spurlin, MD 33301 Woodward Ave, Birmingham, MI 48009-0905 Ph: (248) 642-9111 | David Vincent Spurlin, MD 33301 Woodward Ave, Birmingham, MI 48009-0905 Ph: (248) 642-9111 |
News Archive
Less than 24 hours after Republicans won control of the House, soon-to-be-speaker John Boehner denounced the new health care law, saying it would "kill jobs in America, ruin the best health care system in the world, and bankrupt our country" - and renewed his vow to try to repeal it. Kaiser Health News asked people around the country to answer the following question: "If you ended up in an elevator with Rep. Boehner, what single thing would you urge him to do about health care in this country? (Kaiser Health News).
Link Resources, Inc. announced today the completion of a share exchange transaction and concurrent US$12 million private placement pursuant to which it acquired the parent company of Yantai Bohai Pharmaceuticals Group Co., Ltd. ("Bohai").
AMAG Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has accepted for review the company's supplemental new drug application (sNDA) for Feraheme (ferumoxytol) Injection for Intravenous (IV) use, which was submitted to the FDA in December 2012.
Two multinational clinical studies indicate that the RDI's system for predicting how HIV and AIDS patients will respond to different drugs could be a useful tool with potential clinical and economic benefits. The studies, published in the January issue of AIDS Patient Care and STDs, involved highly experienced physicians in the USA, Canada and Italy who used the system to help them select the optimum combination of HIV drugs for patients whose therapy was failing.
› Verified 7 days ago
Michael Steven Borkin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 S Adams Rd, Ste. 101, Birmingham, MI 48009 Phone: 248-646-9597 Fax: 248-646-4067 | |
Dr. Mitchell S Shek, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 S Adams Rd, Suite 101, Birmingham, MI 48009 Phone: 248-646-9597 Fax: 248-646-4067 | |
Dr. Martin M Abbrecht, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 800 S Adams Rd, Suite 101, Birmingham, MI 48009 Phone: 248-646-9597 Fax: 248-646-4067 | |
Dr. Lori A. Haddad, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2151 E 14 Mile Rd, Birmingham, MI 48009 Phone: 248-645-0830 Fax: 248-645-2863 | |
Mrs. Debra Elyse Kaplan, PA Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 S Adams Rd, Suite 101, Birmingham, MI 48009 Phone: 248-646-9597 Fax: 248-646-4067 | |
Dr. Melvin B Sharf, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 974 S Bates St, Birmingham, MI 48009 Phone: 248-593-9795 Fax: 248-593-9796 |